Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Placebo-Controlled, Double-Blind, Phase 2/3 Efficacy and Safety Trial of HLCM051 (MultiStem®) in Patients With Ischemic Stroke

NCT02961504 is registered in ClinicalTrials.gov with Healios K.K. as lead sponsor.

NCT NCT02961504
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02961504 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Placebo-Controlled, Double-Blind, Phase 2/3 Efficacy and Safety Trial of HLCM051 (MultiStem®) in Patients With Ischemic Stroke
Lead sponsor
Healios K.K.
Phase
Phase 2/3
Overall status
Completed
Start date
November 15, 2017
Completion date
February 28, 2023
Enrollment
206 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke, acute